E2 ModeratePreliminaryPEM ?ObservationalPeer-reviewedMachine draft
Activity monitoring and patient-reported outcome measures in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients.
Rekeland, Ingrid G, Sørland, Kari, Bruland, Ove et al. · PloS one · 2022 · DOI
Quick Summary
This study tracked 27 ME/CFS patients for six months using Fitbit activity monitors and questionnaires to understand how symptoms vary day-to-day and whether activity data matches what patients report. Researchers found that people with milder disease had larger swings in their activity levels week-to-week, while those with severe disease stayed consistently low. Activity monitoring proved feasible and useful as a tool alongside patient surveys.
Why It Matters
ME/CFS lacks validated biomarkers, making objective measurement tools valuable for tracking disease patterns and treatment effects. This study demonstrates that continuous activity monitoring is feasible in ME/CFS populations and provides objective data that correlates with patient-experienced symptoms, potentially improving how clinicians and researchers monitor this complex condition.
Observed Findings
- Daily step counts decreased with disease severity: mild disease averaged 5,566 steps/day, moderate 4,991, and severe 1,998 steps/day
- Day-to-day activity variation was substantial (mean 47%, range 25–79%), indicating significant symptom fluctuation within individuals
- Patients with milder baseline disease showed larger week-to-week swings in activity (958 steps maximum difference) compared to those with higher symptom burden (479 steps difference)
- Significant correlations existed between daily steps and multiple patient-reported measures including SF-36 Physical Function, Social Function, and DSQ-SF symptom severity
- Resting heart rates remained stable throughout the six-month monitoring period
Inferred Conclusions
- Continuous wearable activity monitoring is feasible and well-tolerated in ME/CFS populations and provides objective data complementary to self-reported outcome measures
- Activity levels correlate meaningfully with patient-reported symptom severity and functional status
- Disease severity influences both absolute activity levels and the magnitude of day-to-day variability, with milder patients showing greater fluctuation capacity
- Wearable activity trackers combined with standardized questionnaires offer a practical approach for longitudinal disease monitoring in ME/CFS research and clinical settings
What This Study Does Not Prove
This observational study cannot establish causation or prove that activity trackers should replace clinical assessment; it only demonstrates feasibility and correlation. The small sample size, lack of control group, and absence of intervention mean findings may not generalize to all ME/CFS populations. The observed activity improvement over six months does not establish whether this represents natural variation, monitoring effects, or true disease trajectories.
Tags
Symptom:Fatigue
Phenotype:Severe
Method Flag:PEM Not DefinedNo ControlsSmall SampleExploratory Only